• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Rizq Mohammed Kamel AbdelBassir Helal Ola  リズク モハメド・カーメル・アブデルバシール・ヘラル・オラ

ORCIDConnect your ORCID iD *help
… Alternative Names

Rizq Ola  リズク モハメド・カーメル・アブデルバシール・ヘラル・オラ

リズク モハメド・カーメル・アブデルバシール・ヘラル・オラ  リズク モハメド・カーメル・アブデルバシール・ヘラル・オラ

Less
Researcher Number 60823698
Affiliation (Current) 2025: 東京大学, 医科学研究所, 特任助教
Affiliation (based on the past Project Information) *help 2022 – 2024: 東京大学, 医科学研究所, 特任研究員
2018 – 2019: 千葉大学, 大学院医学研究院, 特任研究員
Review Section/Research Field
Principal Investigator
Basic Section 54010:Hematology and medical oncology-related / 0901:Oncology and related fields
Keywords
Principal Investigator
myeloma / Epigenetics / UTX / tumor suppressor / Myeloma / KDM6A / BRAF V600E / mouse model / mature B cells / epigenetics … More / Braf V600E / Multiple myeloma / GSK126 / UNC1999 / EZH2 / multiple myeloma Less
  • Research Projects

    (3 results)
  • Research Products

    (9 results)
  • Co-Researchers

    (1 People)
  •  Identification of genes responsible for the resistance to first line anti-myeloma therapeuticsPrincipal Investigator

    • Principal Investigator
      リズク モハメド・カーメル・アブデルバシール・ヘラル・オラ
    • Project Period (FY)
      2024 – 2026
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 54010:Hematology and medical oncology-related
    • Research Institution
      The University of Tokyo
  •  Dissecting the tumor suppressive role of Utx in multiple myelomaPrincipal Investigator

    • Principal Investigator
      Rizq Ola
    • Project Period (FY)
      2022 – 2023
    • Research Category
      Grant-in-Aid for Early-Career Scientists
    • Review Section
      Basic Section 54010:Hematology and medical oncology-related
    • Research Institution
      The University of Tokyo
  •  The role of UTX in the pathogenesis of multiple myeloma and its therapeutic applicationsPrincipal Investigator

    • Principal Investigator
      リズク モハメド・カーメル・アブデルバシール・ヘラル・オラ
    • Project Period (FY)
      2018 – 2019
    • Research Category
      Grant-in-Aid for Research Activity Start-up
    • Review Section
      0901:Oncology and related fields
    • Research Institution
      Chiba University

All 2023 2022 2019 2018

All Journal Article Presentation

  • [Journal Article] UTX inactivation in germinal center B cells promotes the development of multiple myeloma with extramedullary disease2023

    • Author(s)
      Rizq Ola、Mimura Naoya、Oshima Motohiko、Momose Shuji、Takayama Naoya、Itokawa Naoki、Koide Shuhei、Shibamiya Asuka、Miyamoto-Nagai Yurie、Rizk Mohamed、Nakajima-Takagi Yaeko、Aoyama Kazumasa、Wang Changshan、Saraya Atsunori、Ito Ryoji、Seimiya Masanori、et al
    • Journal Title

      Leukemia

      Volume: 37 Issue: 9 Pages: 1895-1907

    • DOI

      10.1038/s41375-023-01928-7

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-20K07858, KAKENHI-PROJECT-22K08495, KAKENHI-PROJECT-23K05608, KAKENHI-PROJECT-23K06449, KAKENHI-PROJECT-23K07851, KAKENHI-PROJECT-20K07396, KAKENHI-PROJECT-21K08366, KAKENHI-PROJECT-22K16298, KAKENHI-PROJECT-22K16318, KAKENHI-PLANNED-19H05746, KAKENHI-PROJECT-19H05653, KAKENHI-PROJECT-23K27442
  • [Presentation] Chromatin and transcriptomic remodeling by Utx loss and Braf V600E mutation induces myeloma-like disease in mice2023

    • Author(s)
      Ola Rizq
    • Organizer
      The 48th Annual Meeting of the Japanese Society of Myeloma
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-22K16318
  • [Presentation] Utx insufficiency cooperates with BrafV600E mutation in a mouse model of human multiple myeloma2022

    • Author(s)
      Ola Rizq
    • Organizer
      Annual Meeting of the Japanese Cancer Association
    • Data Source
      KAKENHI-PROJECT-22K16318
  • [Presentation] Concurrent Utx loss and Braf V600E expression drives myelomagenesis in mice2022

    • Author(s)
      Ola Rizq
    • Organizer
      Annual Meeting of the Japanese Society of Myeloma
    • Data Source
      KAKENHI-PROJECT-22K16318
  • [Presentation] Loss of Utx Cooperates with Braf V600E Mutation to Induce Myeloma in a Conditional Mouse Model.2019

    • Author(s)
      Ola Rizq
    • Organizer
      第23回造血器腫瘍研究会, 石川県金沢市
    • Data Source
      KAKENHI-PROJECT-19K21281
  • [Presentation] Loss of Utx cooperates with Braf V600E mutation to induce post-germinal center B-cell disorders in mice.2018

    • Author(s)
      Ola Rizq
    • Organizer
      9th JSH International Symposium in Kyoto. 27-28 July 2018. Grand Prince Hotel Kyoto, Kyoto
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-19K21281
  • [Presentation] Development of a novel mouse model of multiple myeloma.2018

    • Author(s)
      Ola Rizq
    • Organizer
      The 43rd Annual Meeting of Japanese Society of myeloma. 12-13 May 2018. Tokyo Bay Makuhari Hall, Chiba
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-19K21281
  • [Presentation] Loss of Utx with Braf V600E induces mature B-cell tumorigenesis in a conditional mouse model.2018

    • Author(s)
      Ola Rizq
    • Organizer
      The 80th Annual Meeting of the Japanese Society of Hematology. 12-14 October 2018. Osaka International Convention Center, Osaka
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-19K21281
  • [Presentation] Loss of Utx with Braf V600E induces mature B-cell tumorigenesis in a conditional mouse model.2018

    • Author(s)
      Ola Rizq
    • Organizer
      The 60th ASH Annual Meeting & Exposition. San Diego, CA, USA.
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-19K21281
  • 1.  SEIMIYA Masanori
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi